• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume9, Issue3

To evaluate the mucormycosis cases in post Covid-19 patients

    Dr. Snehanshu Shukla, Dr. Ranvijay Singh, Dr. Gaurav Kumar

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 3, Pages 134-138

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Aim: To evaluate the mucormycosis cases in post Covid-19 patients.
Methods: This cross-sectional observational study was carried out in the Department of
Microbiology. Basic microbiological methods such as gram stain and KOH smear were
used for the detection of MC in the received clinical specimen and morphology was seen
in the microscope. Patients admitted in our hospital with a history of fever, cough, body
ache and shortness of breath for 4-5 days with have positive report of nasopharyngeal/
oropharyngeal swab for covid19 RT-PCR were included in the present study.
Results: Age, sex and other demography details were collected before sample collection,
the average age of the participants was 60.4 ± 7.5 years and the majority of participants
were male 75%. Although, 45% participants belong to below 50 year age and 55% of
participant belongs to above 50 year age. Out of n=50 specimens, total 9 specimen found
positive for fungal smear i.e. n=6 sputum, n=3 nasal swabs and n=0 BAL specimens.
Conclusions: The present study concluded that the cases of life threatening MC increase
day by day in central India as post complication of covid-19 disease.
Keywords:
    Mucormycosis post Covid-19 disease patients
  • PDF (173 K)
  • XML
(2022). To evaluate the mucormycosis cases in post Covid-19 patients. European Journal of Molecular & Clinical Medicine, 9(3), 134-138.
Dr. Snehanshu Shukla, Dr. Ranvijay Singh, Dr. Gaurav Kumar. "To evaluate the mucormycosis cases in post Covid-19 patients". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 134-138.
(2022). 'To evaluate the mucormycosis cases in post Covid-19 patients', European Journal of Molecular & Clinical Medicine, 9(3), pp. 134-138.
To evaluate the mucormycosis cases in post Covid-19 patients. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 134-138.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 143
  • PDF Download: 148
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus